STOCK TITAN

Allstate (ALL) president sells 32,996 shares in August stock trades

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Allstate Corp executive John E. Dugenske, president of Investments & Corporate Strategy, reported open-market sales of 32,996 shares of Allstate common stock on August 7, 2026. The sales occurred in three tranches at weighted average prices of $270.198, $272.050, and $268.803, each with disclosed price ranges. After these transactions, he reported 341 shares held indirectly through a 401(k) plan.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Dugenske John E
Role Insider
Sold 32,996 shs ($8.89M)
Type Security Shares Price Value
Sale Common Stock F1 3,378 $270.198 $913K
Sale Common Stock F2 3,901 $272.05 $1.06M
Sale Common Stock F3 25,717 $268.803 $6.91M
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 13,054 shares (Direct); Common Stock — 341 shares (Indirect, By 401(k) Plan)
Footnotes (3)
  1. F1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $270.050 to $270.460. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
  2. F2. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $271.570 to $272.090. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
  3. F3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $268.370 to $269.165. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
Shares sold (total) 32,996 shares Aggregate common shares sold on August 7, 2026
Sale tranche 1 3,378 shares at $270.198 Weighted average price; actual prices $270.050–$270.460
Sale tranche 2 3,901 shares at $272.050 Weighted average price; actual prices $271.570–$272.090
Sale tranche 3 25,717 shares at $268.803 Weighted average price; actual prices $268.370–$269.165
Indirect holdings after transactions 341 shares Common stock held indirectly by 401(k) plan
weighted average sale price financial
"Reflects weighted average sale price for open-market sales transaction reported herein."
open-market sales transaction financial
"Reflects weighted average sale price for open-market sales transaction reported herein."
indirect financial
"total_shares_following_transaction: 341.0000, ownership_type: indirect, nature_of_ownership: By 401(k) Plan"
401(k) Plan financial
"nature_of_ownership: By 401(k) Plan"
A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Allstate (ALL) executive John E. Dugenske report in this Form 4?

John E. Dugenske reported selling 32,996 shares of Allstate common stock on August 7, 2026 in open-market transactions and reporting continued indirect ownership of 341 shares through a 401(k) plan.

How many Allstate (ALL) shares did John E. Dugenske sell and at what prices?

He sold 32,996 shares in three blocks at weighted average prices of $270.198, $272.050, and $268.803, with each block’s actual trade prices falling within narrow ranges disclosed in the footnotes.

On what date did the Allstate (ALL) stock sales by John E. Dugenske occur?

All reported transactions occurred on August 7, 2026. On that date, he executed three open-market sale transactions in Allstate common stock, each reported with a weighted average price and detailed intraday price ranges in the accompanying footnotes.

Does John E. Dugenske still hold Allstate (ALL) shares after these transactions?

Yes. Following the reported sales, he reported 341 shares of Allstate common stock held indirectly through a 401(k) plan, according to the holding entry included alongside the transaction details.

Were the Allstate (ALL) stock sales made under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes describe the trades as open-market sales with weighted average prices, without stating that they were executed under a 10b5-1 trading plan.

What role does John E. Dugenske hold at Allstate (ALL) in this Form 4?

He is identified as President, Investments & Corporate Strategy at Allstate. The Form 4 lists this position while detailing his reported sales of Allstate common stock and remaining indirect holdings through a retirement plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dugenske John E

(Last)(First)(Middle)
C/O THE ALLSTATE CORPORATION
3100 SANDERS ROAD

(Street)
NORTHBROOK ILLINOIS 60062

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
Officer (give title below)XOther (specify below)
Pres, Invest. & Corp. Strategy
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/07/2026S3,378D$270.198(1)42,672D
Common Stock08/07/2026S3,901D$272.05(2)38,771D
Common Stock08/07/2026S25,717D$268.803(3)13,054D
Common Stock341IBy 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $270.050 to $270.460. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
2. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $271.570 to $272.090. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
3. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $268.370 to $269.165. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
/s/ Meghan E. Jauhar, attorney-in-fact for John E. Dugenske08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)